CERUTI, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 5.573
EU - Europa 4.614
AS - Asia 2.020
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 8
OC - Oceania 7
Totale 12.265
Nazione #
US - Stati Uniti d'America 5.541
CN - Cina 1.003
IT - Italia 743
IE - Irlanda 727
DE - Germania 654
SE - Svezia 587
FI - Finlandia 452
KR - Corea 414
UA - Ucraina 407
JP - Giappone 299
FR - Francia 292
VN - Vietnam 208
GB - Regno Unito 178
PL - Polonia 178
AT - Austria 143
DK - Danimarca 120
IN - India 43
RU - Federazione Russa 42
CA - Canada 29
NL - Olanda 27
BE - Belgio 23
SN - Senegal 23
SG - Singapore 22
EU - Europa 13
UZ - Uzbekistan 12
IR - Iran 9
GR - Grecia 8
AU - Australia 6
BR - Brasile 6
CZ - Repubblica Ceca 5
ES - Italia 4
HU - Ungheria 4
RO - Romania 4
NO - Norvegia 3
PT - Portogallo 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CH - Svizzera 2
MX - Messico 2
MY - Malesia 2
RS - Serbia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
CR - Costa Rica 1
DZ - Algeria 1
HK - Hong Kong 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
SI - Slovenia 1
TW - Taiwan 1
Totale 12.265
Città #
Chandler 747
Beijing 742
Ann Arbor 730
Dublin 725
Jacksonville 422
Dearborn 300
Princeton 234
Houston 183
Boston 181
Dong Ket 177
Warsaw 174
Wilmington 171
Ashburn 157
Villeurbanne 156
Fairfield 151
Medford 146
Vienna 143
Torino 127
Woodbridge 115
Nyköping 95
Frankfurt am Main 78
Munich 76
Fremont 74
Boardman 65
Seattle 64
Milan 60
Cambridge 54
Pisa 45
New York 34
Hefei 32
Falls Church 31
Norwalk 28
Kunming 26
Rome 24
Verona 24
Redwood City 23
Nanjing 21
Brussels 19
Guangzhou 18
Washington 17
Düsseldorf 15
Moscow 15
Nanchang 15
Buffalo 14
Cimitile 14
Helsinki 14
Hebei 12
San Mateo 12
Hangzhou 11
Pune 11
Toronto 11
Zhengzhou 11
Harbin 9
Chongqing 8
Palermo 8
Phoenix 8
Shanghai 8
Wuhan 8
Fuzhou 7
Lachine 7
San Diego 7
Tulsa 7
Bari 6
Hanover 6
Jinan 6
Paderno Dugnano 6
Shenyang 6
Dallas 5
Loreto 5
Mountain View 5
Napoli 5
Shenzhen 5
Turin 5
Ardabil 4
Brescia 4
Changsha 4
Lavagna 4
Leawood 4
London 4
Matsuyama 4
Monmouth Junction 4
Philadelphia 4
Recife 4
Redmond 4
Ruda Śląska 4
University Park 4
Bologna 3
Budapest 3
Castello di Godego 3
Des Moines 3
Hamilton 3
Iesi 3
Kharkiv 3
Ningbo 3
Ottawa 3
Pavia 3
Radolfzell 3
Salerno 3
San Giuliano Milanese 3
Stavanger 3
Totale 7.075
Nome #
Carbammati lipidici di farmaci antitumorali. 408
Antifungal activity of bis-azasqualenes, inhibitors of oxidosqualene cyclase 205
Farmaci macromolecolari: veicolazione e direzionamento mediante albumina umana 187
Study of (1-alkoxyethyl)diphenylphosphine oxides. I. Syntheses and structural analyses of phenylethoxy, methoxy and isopentyloxy derivatives. 174
Robinia “Georgia da Torino”. 160
1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis[1,2,4]triazolo[4,3-a:3’,4’-d] [1,5]benzodiazepines and relate compounds endowed with in vitro cytotoxic properties 155
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase. 147
Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells 145
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 145
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae 141
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase 136
10 and 19-azasqualene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase from pig liver. 134
Comparison of experimental and molecular modelling results on phosphine oxides. 132
A Simple Synthesis and some Chemical Properties of Benzo-1,4-dithiafulvenes 123
Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy 118
Study of (1-alkoxyethyl)diphenylphosphine oxides. II. Conformational analysis by theoretical calculations. 118
Study of (1-alkoxyethyl)diphenylphosphine oxides. IV. Conclusive conformational study by NMR and molecular mechanics calculations. 115
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases 115
Study of (1-alkoxyethyl)diphenylphosphine oxides. III. Nuclear magnetic resonance analysis. 113
Synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives as Inhibitors of Liver and Yeast Oxidosqualene Cyclase. 110
[Antiproliferative effect of an extract of Aspergillus terreus] 107
Studio del metabolismo in vivo nel ratto dell'antiparkinson Budipina. 101
Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry 100
Structure and reactivity of the dammarenyl cation: configurational transmission in triterpene synthesis 96
Interaction of lipophilic gemcitabine prodrugs with biomembrane models studied by Langmuir-Blodgett technique 95
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae. 95
Sintesi di aldeidi per omologazione di composti carbonilici, via 1,4-benzoditiafulveni. 91
An NMR and molecular mechanics study of squalene and squalene derivatives 88
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 87
Synthesis and biological activity of 22,23-epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide - lanosterol cyclase. 86
Synthesis of a squalenoid oxaziridine and other new classes of squalene derivatives, as inhibitors of sterol biosynthesis. 83
Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface 82
Sintesi di inibitori suicidi dello squalene 2,3-epossido ciclasi. 80
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 79
2,3-oxidosqualene cyclase and squalene epoxidase: enzymology, mechanism and inhibitors 79
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors 78
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae 76
New DSPE-PEG-Folate conjugates for liposomal drug targeting 76
Azasqualeni N-ossidi e bis-azasqualeni, inibitori dell'enzima squalene epossido ciclasi. 75
The squalene-2,3-epoxide cyclase as a model for the development of new drugs. 74
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors. 74
Synthesis, characterization and biological activity of new cationic lipids active for gene transfection. 73
Characterization and partial purification of squalene-2,3-oxide cyclase from Saccharomyces cerevisiae. 73
The metabolic fate of the anti-parkinsonian drug budipine in rats. 73
2-Aza-2,3-dihydrosqualene: biodistribution and pharmacokinetic properties in mice. 73
2,3-oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 73
Vinyl sulfide derivatives of oxidosqualene, as inhibitors of oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae. 73
Total synthesis of the hypocholesterolemic and antifungal drug 10-azasqualene 2,3-epoxide, the first non-cyclized analogue of the C-8 carbonium ion formed during squalene epoxide cyclization. 72
Bis(2-Acyloxy or Aroylxybenzenethiolates)Mercury (II) as Inhibitors of “Fusarium” 71
2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 71
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase. 71
N-oxide as a potential function in the design of enzyme inhibitors. Application to 2,3-epoxysqualene-sterol cyclases. 71
2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase. 70
Synthesis of HEI analogues of the C-20 carbocation forming during lanosterol biosynthesis, as hypocholesterolemics. 70
2,3-Oxidosqualene cyclase and squalene epoxidase as target enzymes for the development of new sterol biosynthesis inhibitors 70
Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives. 69
A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody. 69
A new "solid phase" procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates). 69
Synthesis of squalenoid acetylenes and allenes, as inhibitors of squalene epoxidase. 69
2,3,4,5-Tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 68
Synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 67
Synthesis and biological activity of azasqualenes, bis-azasqualenes and derivatives. 67
Synthesis of tritium-labelled 19-azasqualene 2,3-epoxide and derivatives, as probes to study their hypocholesterolemic activity. 67
The in vitro metabolism of 1,3-thiazolidine derivatives of theophylline: a study on structure-metabolism correlation. 67
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 66
A convenient synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 66
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase. 65
Antifungal and cytotoxic activiti of two inhibitors of 2,3-oxidosqualene cyclase 65
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase 65
22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase. 64
Synthesis of new gemcitabine prodrugs for liposome and nanoparticle encapsulation 63
Sostanze mutagene e cancerogene in funghi del genere Agaricus. 62
2,3,4,5-tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 62
Azasqualene alcohol and derivatives. New selective inhibitors of 2,3-oxidosqualene cyclase. 62
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids 61
Biocompatible micelles based on amphiphilic polyaspartamide-squalene derivatives as potential colloidal drug carriers. 61
In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study. 61
(E) and (Z)-29-methylidene-2,3-oxidosqualene as stereospecific mechanism-based inhibitors of 2,3-oxidosqualene cyclase. 60
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide. 60
Studio comparato dell'attività inibitoria di derivati squalenoidi acetilenici ed allenici, nei confronti dell'enzima squalene epossidasi e delle monoossigenasi P-450 dipendenti. 60
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 59
Rational inhibition of sterol biosynthesis: new time-dependent inhibitors of 2,3-oxidosqualene cyclase. 59
Total synthesis and inhibition of sterol biosynthesis by 10-azasqualene 2,3-epoxide, a high-energy intermediate analogue 58
Metabolismo ossidativo di funzioni acetaliche e tioacetaliche cicliche: studio della correlazione struttura metabolismo. 58
Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique 57
Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes. Evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage. 57
Studio del metabolismo del 7-(1,3-ditiolan-2-ilmetil)teofillina, un nuovo farmaco ad attività antibroncospastica e mucolitica. 57
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 56
Incorporation of lipophilic gemcitabine prodrugs in liposomes 56
An NMR study of 2-aza and 19-azasqualene derivatives. Primo Congresso Congiunto Italiano-Svizzero di Chimica Farmaceutica, 55
Synthesis and inhibition of cholesterol biosynthesis by azasqualene alcohol and derivatives. 55
1H-NMR and 13C-NMR studies for the assignment of the structure of (6E)-10-azasqualene 2,3-epoxide and (6Z)-10-azasqualene 2,3-epoxide and their correlation with hypocholesterolemic and antifungal activity. 55
Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase. 55
Sintesi ed attività biologica di azasqualeni, bis-azasqualeni e derivati. 55
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici. 54
Preparation, characterization, cytotoxicity and pharmacokinetcs of liposomes containing lipophilic gemcitabine prodrugs 53
2-Aza-2,3-dihydrosqualene and its N-oxide as inhibitors of sterol biosynthesis in bramble cell suspension cultures. 53
An NMR and molecular mechanics study of squalene and squalene derivatives. 53
Synthesis of new inhibitors of oxidosqualene cyclase. 53
Synthesis and antibronchospastic activity of theophylline thioacetal derivatives. 52
Totale 8.612
Categoria #
all - tutte 33.212
article - articoli 0
book - libri 0
conference - conferenze 12.629
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019400 0 0 0 0 0 0 0 0 0 57 243 100
2019/20202.052 75 130 229 127 114 345 275 89 266 172 143 87
2020/20211.410 182 49 86 70 127 73 117 37 140 96 126 307
2021/20221.901 71 56 66 139 114 65 144 138 60 140 391 517
2022/20232.335 295 133 37 235 212 697 245 122 212 17 97 33
2023/2024637 140 182 54 30 51 92 19 36 3 30 0 0
Totale 12.878